Table 2 Examples of ongoing sipuleucel-T combination studies

Concurrent vs. sequential sipuleucel-T and abiraterone

NCT01487863

Randomized phase II, Reported in 2015 [44]

Sipuleucel-T +/- RT

NCT01807065

Randomized Phase II, Recruiting, Expected completion date June 2017

Sipuleucel-T +/- pTVG-HP DNA booster vaccine

NCT01706458

Randomized pilot study, Recruiting, Expected completion date December 2016

Sipuleucel-T + indoximod

NCT01560923

Randomized phase II Recruiting, Expected completion date December 2016

Sipuleucel-T +/- ipilimumab

NCT01804465

Randomized phase II, Recruiting, Expected completion date December 2017

Sipuleucel-T +/- radium - 223

NCT02463799

Randomized phase II, Recruiting, Expected completion date December 2018